nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP3A4—Estropipate—osteoporosis	0.0705	0.158	CbGbCtD
Ipratropium bromide—CYP3A4—Calcitriol—osteoporosis	0.0705	0.158	CbGbCtD
Ipratropium bromide—CYP2D6—Cholecalciferol—osteoporosis	0.0571	0.128	CbGbCtD
Ipratropium bromide—CYP3A4—Ergocalciferol—osteoporosis	0.0563	0.126	CbGbCtD
Ipratropium bromide—CYP3A4—Raloxifene—osteoporosis	0.047	0.105	CbGbCtD
Ipratropium bromide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0454	0.102	CbGbCtD
Ipratropium bromide—CYP3A4—Cholecalciferol—osteoporosis	0.0363	0.0814	CbGbCtD
Ipratropium bromide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0333	0.0748	CbGbCtD
Ipratropium bromide—CYP3A4—Estradiol—osteoporosis	0.0293	0.0656	CbGbCtD
Ipratropium bromide—Infection—Pamidronate—osteoporosis	0.000606	0.00109	CcSEcCtD
Ipratropium bromide—Rhinitis—Estradiol—osteoporosis	0.000606	0.00109	CcSEcCtD
Ipratropium bromide—Urticaria—Calcitriol—osteoporosis	0.000605	0.00109	CcSEcCtD
Ipratropium bromide—Haemorrhage—Estradiol—osteoporosis	0.000604	0.00109	CcSEcCtD
Ipratropium bromide—Palpitations—Zoledronate—osteoporosis	0.000603	0.00109	CcSEcCtD
Ipratropium bromide—Abdominal pain—Calcitriol—osteoporosis	0.000602	0.00109	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Estradiol—osteoporosis	0.000601	0.00109	CcSEcCtD
Ipratropium bromide—Angioedema—Conjugated Estrogens—osteoporosis	0.0006	0.00109	CcSEcCtD
Ipratropium bromide—Pharyngitis—Estradiol—osteoporosis	0.000599	0.00108	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Estropipate—osteoporosis	0.000598	0.00108	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Pamidronate—osteoporosis	0.000598	0.00108	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Estradiol—osteoporosis	0.000597	0.00108	CcSEcCtD
Ipratropium bromide—Vomiting—Etidronic acid—osteoporosis	0.000596	0.00108	CcSEcCtD
Ipratropium bromide—Cough—Zoledronate—osteoporosis	0.000595	0.00108	CcSEcCtD
Ipratropium bromide—Tachycardia—Pamidronate—osteoporosis	0.000595	0.00108	CcSEcCtD
Ipratropium bromide—Urethral disorder—Estradiol—osteoporosis	0.000592	0.00107	CcSEcCtD
Ipratropium bromide—Rash—Etidronic acid—osteoporosis	0.000591	0.00107	CcSEcCtD
Ipratropium bromide—Dermatitis—Etidronic acid—osteoporosis	0.000591	0.00107	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Pamidronate—osteoporosis	0.000589	0.00107	CcSEcCtD
Ipratropium bromide—Hypertension—Zoledronate—osteoporosis	0.000589	0.00106	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Alendronate—osteoporosis	0.000589	0.00106	CcSEcCtD
Ipratropium bromide—Headache—Etidronic acid—osteoporosis	0.000588	0.00106	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000584	0.00106	CcSEcCtD
Ipratropium bromide—Asthenia—Estropipate—osteoporosis	0.000582	0.00105	CcSEcCtD
Ipratropium bromide—Visual impairment—Estradiol—osteoporosis	0.000582	0.00105	CcSEcCtD
Ipratropium bromide—Chest pain—Zoledronate—osteoporosis	0.000581	0.00105	CcSEcCtD
Ipratropium bromide—Myalgia—Zoledronate—osteoporosis	0.000581	0.00105	CcSEcCtD
Ipratropium bromide—Palpitations—Conjugated Estrogens—osteoporosis	0.000581	0.00105	CcSEcCtD
Ipratropium bromide—Insomnia—Risedronate—osteoporosis	0.00058	0.00105	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000577	0.00104	CcSEcCtD
Ipratropium bromide—Paraesthesia—Risedronate—osteoporosis	0.000576	0.00104	CcSEcCtD
Ipratropium bromide—Pruritus—Estropipate—osteoporosis	0.000574	0.00104	CcSEcCtD
Ipratropium bromide—Asthenia—Alendronate—osteoporosis	0.000573	0.00104	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ibandronate—osteoporosis	0.000573	0.00104	CcSEcCtD
Ipratropium bromide—Cough—Conjugated Estrogens—osteoporosis	0.000573	0.00104	CcSEcCtD
Ipratropium bromide—Dyspnoea—Risedronate—osteoporosis	0.000572	0.00103	CcSEcCtD
Ipratropium bromide—Hypotension—Pamidronate—osteoporosis	0.00057	0.00103	CcSEcCtD
Ipratropium bromide—Dry mouth—Zoledronate—osteoporosis	0.000568	0.00103	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000568	0.00103	CcSEcCtD
Ipratropium bromide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000567	0.00102	CcSEcCtD
Ipratropium bromide—Pruritus—Alendronate—osteoporosis	0.000565	0.00102	CcSEcCtD
Ipratropium bromide—Dyspepsia—Risedronate—osteoporosis	0.000565	0.00102	CcSEcCtD
Ipratropium bromide—Eye disorder—Estradiol—osteoporosis	0.000564	0.00102	CcSEcCtD
Ipratropium bromide—Tinnitus—Estradiol—osteoporosis	0.000563	0.00102	CcSEcCtD
Ipratropium bromide—Constipation—Ethinyl Estradiol—osteoporosis	0.000562	0.00102	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Calcitriol—osteoporosis	0.000561	0.00101	CcSEcCtD
Ipratropium bromide—Flushing—Estradiol—osteoporosis	0.000561	0.00101	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Estradiol—osteoporosis	0.000561	0.00101	CcSEcCtD
Ipratropium bromide—Chest pain—Conjugated Estrogens—osteoporosis	0.000559	0.00101	CcSEcCtD
Ipratropium bromide—Myalgia—Conjugated Estrogens—osteoporosis	0.000559	0.00101	CcSEcCtD
Ipratropium bromide—Asthenia—Ibandronate—osteoporosis	0.000558	0.00101	CcSEcCtD
Ipratropium bromide—Nausea—Etidronic acid—osteoporosis	0.000557	0.00101	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Zoledronate—osteoporosis	0.000557	0.00101	CcSEcCtD
Ipratropium bromide—Oedema—Zoledronate—osteoporosis	0.000557	0.00101	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000555	0.001	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000555	0.001	CcSEcCtD
Ipratropium bromide—Diarrhoea—Estropipate—osteoporosis	0.000555	0.001	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000554	0.001	CcSEcCtD
Ipratropium bromide—Infection—Zoledronate—osteoporosis	0.000553	0.001	CcSEcCtD
Ipratropium bromide—Fatigue—Risedronate—osteoporosis	0.000553	0.000999	CcSEcCtD
Ipratropium bromide—Insomnia—Pamidronate—osteoporosis	0.000551	0.000997	CcSEcCtD
Ipratropium bromide—Pruritus—Ibandronate—osteoporosis	0.000551	0.000995	CcSEcCtD
Ipratropium bromide—Constipation—Risedronate—osteoporosis	0.000548	0.000991	CcSEcCtD
Ipratropium bromide—Pain—Risedronate—osteoporosis	0.000548	0.000991	CcSEcCtD
Ipratropium bromide—Paraesthesia—Pamidronate—osteoporosis	0.000547	0.000989	CcSEcCtD
Ipratropium bromide—Diarrhoea—Alendronate—osteoporosis	0.000547	0.000988	CcSEcCtD
Ipratropium bromide—Asthenia—Calcitriol—osteoporosis	0.000547	0.000988	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Zoledronate—osteoporosis	0.000546	0.000987	CcSEcCtD
Ipratropium bromide—Immune system disorder—Estradiol—osteoporosis	0.000546	0.000986	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Estradiol—osteoporosis	0.000544	0.000984	CcSEcCtD
Ipratropium bromide—Dyspnoea—Pamidronate—osteoporosis	0.000544	0.000982	CcSEcCtD
Ipratropium bromide—Tachycardia—Zoledronate—osteoporosis	0.000543	0.000982	CcSEcCtD
Ipratropium bromide—Somnolence—Pamidronate—osteoporosis	0.000542	0.00098	CcSEcCtD
Ipratropium bromide—Skin disorder—Zoledronate—osteoporosis	0.000541	0.000978	CcSEcCtD
Ipratropium bromide—Pruritus—Calcitriol—osteoporosis	0.000539	0.000974	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Zoledronate—osteoporosis	0.000538	0.000973	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000538	0.000972	CcSEcCtD
Ipratropium bromide—Diarrhoea—Raloxifene—osteoporosis	0.000538	0.000972	CcSEcCtD
Ipratropium bromide—Dyspepsia—Pamidronate—osteoporosis	0.000537	0.00097	CcSEcCtD
Ipratropium bromide—Dizziness—Estropipate—osteoporosis	0.000537	0.00097	CcSEcCtD
Ipratropium bromide—Oedema—Conjugated Estrogens—osteoporosis	0.000536	0.000969	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000536	0.000969	CcSEcCtD
Ipratropium bromide—Infection—Conjugated Estrogens—osteoporosis	0.000533	0.000963	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ibandronate—osteoporosis	0.000532	0.000962	CcSEcCtD
Ipratropium bromide—Dizziness—Alendronate—osteoporosis	0.000529	0.000955	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000526	0.000951	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000526	0.00095	CcSEcCtD
Ipratropium bromide—Fatigue—Pamidronate—osteoporosis	0.000526	0.00095	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Risedronate—osteoporosis	0.000524	0.000948	CcSEcCtD
Ipratropium bromide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000523	0.000946	CcSEcCtD
Ipratropium bromide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000523	0.000944	CcSEcCtD
Ipratropium bromide—Pain—Pamidronate—osteoporosis	0.000521	0.000942	CcSEcCtD
Ipratropium bromide—Constipation—Pamidronate—osteoporosis	0.000521	0.000942	CcSEcCtD
Ipratropium bromide—Diarrhoea—Calcitriol—osteoporosis	0.000521	0.000942	CcSEcCtD
Ipratropium bromide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000521	0.000941	CcSEcCtD
Ipratropium bromide—Hypotension—Zoledronate—osteoporosis	0.00052	0.00094	CcSEcCtD
Ipratropium bromide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00052	0.00094	CcSEcCtD
Ipratropium bromide—Dizziness—Raloxifene—osteoporosis	0.00052	0.00094	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000518	0.000937	CcSEcCtD
Ipratropium bromide—Flatulence—Estradiol—osteoporosis	0.000518	0.000937	CcSEcCtD
Ipratropium bromide—Tension—Estradiol—osteoporosis	0.000516	0.000933	CcSEcCtD
Ipratropium bromide—Vomiting—Estropipate—osteoporosis	0.000516	0.000933	CcSEcCtD
Ipratropium bromide—Dysgeusia—Estradiol—osteoporosis	0.000515	0.000931	CcSEcCtD
Ipratropium bromide—Dizziness—Ibandronate—osteoporosis	0.000515	0.00093	CcSEcCtD
Ipratropium bromide—Rash—Estropipate—osteoporosis	0.000512	0.000925	CcSEcCtD
Ipratropium bromide—Dermatitis—Estropipate—osteoporosis	0.000511	0.000924	CcSEcCtD
Ipratropium bromide—Nervousness—Estradiol—osteoporosis	0.000511	0.000923	CcSEcCtD
Ipratropium bromide—Urticaria—Risedronate—osteoporosis	0.000509	0.000921	CcSEcCtD
Ipratropium bromide—Back pain—Estradiol—osteoporosis	0.000509	0.000919	CcSEcCtD
Ipratropium bromide—Headache—Estropipate—osteoporosis	0.000508	0.000919	CcSEcCtD
Ipratropium bromide—Vomiting—Alendronate—osteoporosis	0.000508	0.000919	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000507	0.000917	CcSEcCtD
Ipratropium bromide—Abdominal pain—Risedronate—osteoporosis	0.000507	0.000916	CcSEcCtD
Ipratropium bromide—Rash—Alendronate—osteoporosis	0.000504	0.000911	CcSEcCtD
Ipratropium bromide—Insomnia—Zoledronate—osteoporosis	0.000504	0.00091	CcSEcCtD
Ipratropium bromide—Dermatitis—Alendronate—osteoporosis	0.000503	0.00091	CcSEcCtD
Ipratropium bromide—Hypotension—Conjugated Estrogens—osteoporosis	0.000501	0.000906	CcSEcCtD
Ipratropium bromide—Headache—Alendronate—osteoporosis	0.000501	0.000905	CcSEcCtD
Ipratropium bromide—Paraesthesia—Zoledronate—osteoporosis	0.0005	0.000904	CcSEcCtD
Ipratropium bromide—Vomiting—Raloxifene—osteoporosis	0.0005	0.000903	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000499	0.000901	CcSEcCtD
Ipratropium bromide—Dyspnoea—Zoledronate—osteoporosis	0.000496	0.000897	CcSEcCtD
Ipratropium bromide—Rash—Raloxifene—osteoporosis	0.000496	0.000896	CcSEcCtD
Ipratropium bromide—Dermatitis—Raloxifene—osteoporosis	0.000495	0.000895	CcSEcCtD
Ipratropium bromide—Somnolence—Zoledronate—osteoporosis	0.000495	0.000895	CcSEcCtD
Ipratropium bromide—Vomiting—Ibandronate—osteoporosis	0.000495	0.000894	CcSEcCtD
Ipratropium bromide—Tremor—Estradiol—osteoporosis	0.000493	0.00089	CcSEcCtD
Ipratropium bromide—Headache—Raloxifene—osteoporosis	0.000492	0.00089	CcSEcCtD
Ipratropium bromide—Rash—Ibandronate—osteoporosis	0.000491	0.000887	CcSEcCtD
Ipratropium bromide—Dermatitis—Ibandronate—osteoporosis	0.00049	0.000886	CcSEcCtD
Ipratropium bromide—Dyspepsia—Zoledronate—osteoporosis	0.00049	0.000886	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000489	0.000883	CcSEcCtD
Ipratropium bromide—Headache—Ibandronate—osteoporosis	0.000487	0.000881	CcSEcCtD
Ipratropium bromide—Insomnia—Conjugated Estrogens—osteoporosis	0.000485	0.000877	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000485	0.000876	CcSEcCtD
Ipratropium bromide—Vomiting—Calcitriol—osteoporosis	0.000484	0.000875	CcSEcCtD
Ipratropium bromide—Nausea—Estropipate—osteoporosis	0.000482	0.000871	CcSEcCtD
Ipratropium bromide—Abdominal pain—Pamidronate—osteoporosis	0.000482	0.000871	CcSEcCtD
Ipratropium bromide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000481	0.00087	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000481	0.000869	CcSEcCtD
Ipratropium bromide—Angioedema—Estradiol—osteoporosis	0.00048	0.000868	CcSEcCtD
Ipratropium bromide—Rash—Calcitriol—osteoporosis	0.00048	0.000868	CcSEcCtD
Ipratropium bromide—Fatigue—Zoledronate—osteoporosis	0.00048	0.000868	CcSEcCtD
Ipratropium bromide—Dermatitis—Calcitriol—osteoporosis	0.00048	0.000867	CcSEcCtD
Ipratropium bromide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000478	0.000864	CcSEcCtD
Ipratropium bromide—Headache—Calcitriol—osteoporosis	0.000477	0.000863	CcSEcCtD
Ipratropium bromide—Somnolence—Conjugated Estrogens—osteoporosis	0.000477	0.000862	CcSEcCtD
Ipratropium bromide—Constipation—Zoledronate—osteoporosis	0.000476	0.000861	CcSEcCtD
Ipratropium bromide—Pain—Zoledronate—osteoporosis	0.000476	0.000861	CcSEcCtD
Ipratropium bromide—Nausea—Alendronate—osteoporosis	0.000475	0.000858	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Risedronate—osteoporosis	0.000472	0.000854	CcSEcCtD
Ipratropium bromide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000472	0.000853	CcSEcCtD
Ipratropium bromide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000472	0.000853	CcSEcCtD
Ipratropium bromide—Nausea—Raloxifene—osteoporosis	0.000467	0.000844	CcSEcCtD
Ipratropium bromide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000465	0.000841	CcSEcCtD
Ipratropium bromide—Palpitations—Estradiol—osteoporosis	0.000465	0.00084	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000463	0.000837	CcSEcCtD
Ipratropium bromide—Fatigue—Conjugated Estrogens—osteoporosis	0.000462	0.000836	CcSEcCtD
Ipratropium bromide—Nausea—Ibandronate—osteoporosis	0.000462	0.000835	CcSEcCtD
Ipratropium bromide—Asthenia—Risedronate—osteoporosis	0.00046	0.000832	CcSEcCtD
Ipratropium bromide—Cough—Estradiol—osteoporosis	0.000459	0.000829	CcSEcCtD
Ipratropium bromide—Constipation—Conjugated Estrogens—osteoporosis	0.000459	0.000829	CcSEcCtD
Ipratropium bromide—Pain—Conjugated Estrogens—osteoporosis	0.000459	0.000829	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000455	0.000823	CcSEcCtD
Ipratropium bromide—Hypertension—Estradiol—osteoporosis	0.000454	0.000821	CcSEcCtD
Ipratropium bromide—Pruritus—Risedronate—osteoporosis	0.000454	0.00082	CcSEcCtD
Ipratropium bromide—Nausea—Calcitriol—osteoporosis	0.000452	0.000818	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00045	0.000813	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Pamidronate—osteoporosis	0.000449	0.000812	CcSEcCtD
Ipratropium bromide—Chest pain—Estradiol—osteoporosis	0.000448	0.000809	CcSEcCtD
Ipratropium bromide—Myalgia—Estradiol—osteoporosis	0.000448	0.000809	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000445	0.000804	CcSEcCtD
Ipratropium bromide—Urticaria—Zoledronate—osteoporosis	0.000442	0.0008	CcSEcCtD
Ipratropium bromide—Abdominal pain—Zoledronate—osteoporosis	0.00044	0.000796	CcSEcCtD
Ipratropium bromide—Diarrhoea—Risedronate—osteoporosis	0.000439	0.000793	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000438	0.000792	CcSEcCtD
Ipratropium bromide—Dry mouth—Estradiol—osteoporosis	0.000438	0.000791	CcSEcCtD
Ipratropium bromide—Asthenia—Pamidronate—osteoporosis	0.000437	0.000791	CcSEcCtD
Ipratropium bromide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000435	0.000786	CcSEcCtD
Ipratropium bromide—Pruritus—Pamidronate—osteoporosis	0.000431	0.00078	CcSEcCtD
Ipratropium bromide—Oedema—Estradiol—osteoporosis	0.000429	0.000776	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Estradiol—osteoporosis	0.000429	0.000776	CcSEcCtD
Ipratropium bromide—Infection—Estradiol—osteoporosis	0.000426	0.000771	CcSEcCtD
Ipratropium bromide—Urticaria—Conjugated Estrogens—osteoporosis	0.000426	0.00077	CcSEcCtD
Ipratropium bromide—Dizziness—Risedronate—osteoporosis	0.000424	0.000767	CcSEcCtD
Ipratropium bromide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000424	0.000766	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Estradiol—osteoporosis	0.000421	0.000761	CcSEcCtD
Ipratropium bromide—Tachycardia—Estradiol—osteoporosis	0.000419	0.000757	CcSEcCtD
Ipratropium bromide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000418	0.000756	CcSEcCtD
Ipratropium bromide—Diarrhoea—Pamidronate—osteoporosis	0.000417	0.000754	CcSEcCtD
Ipratropium bromide—Skin disorder—Estradiol—osteoporosis	0.000417	0.000753	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Estradiol—osteoporosis	0.000415	0.00075	CcSEcCtD
Ipratropium bromide—Rash—Ethinyl Estradiol—osteoporosis	0.000415	0.00075	CcSEcCtD
Ipratropium bromide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000414	0.000749	CcSEcCtD
Ipratropium bromide—Headache—Ethinyl Estradiol—osteoporosis	0.000412	0.000745	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Zoledronate—osteoporosis	0.00041	0.000742	CcSEcCtD
Ipratropium bromide—Vomiting—Risedronate—osteoporosis	0.000408	0.000737	CcSEcCtD
Ipratropium bromide—Rash—Risedronate—osteoporosis	0.000404	0.000731	CcSEcCtD
Ipratropium bromide—Dermatitis—Risedronate—osteoporosis	0.000404	0.00073	CcSEcCtD
Ipratropium bromide—Dizziness—Pamidronate—osteoporosis	0.000403	0.000729	CcSEcCtD
Ipratropium bromide—Headache—Risedronate—osteoporosis	0.000402	0.000726	CcSEcCtD
Ipratropium bromide—Asthenia—Zoledronate—osteoporosis	0.0004	0.000722	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000395	0.000714	CcSEcCtD
Ipratropium bromide—Pruritus—Zoledronate—osteoporosis	0.000394	0.000712	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000391	0.000707	CcSEcCtD
Ipratropium bromide—Nausea—Ethinyl Estradiol—osteoporosis	0.000391	0.000706	CcSEcCtD
Ipratropium bromide—Insomnia—Estradiol—osteoporosis	0.000388	0.000702	CcSEcCtD
Ipratropium bromide—Vomiting—Pamidronate—osteoporosis	0.000388	0.000701	CcSEcCtD
Ipratropium bromide—Paraesthesia—Estradiol—osteoporosis	0.000385	0.000696	CcSEcCtD
Ipratropium bromide—Asthenia—Conjugated Estrogens—osteoporosis	0.000385	0.000695	CcSEcCtD
Ipratropium bromide—Rash—Pamidronate—osteoporosis	0.000384	0.000695	CcSEcCtD
Ipratropium bromide—Dermatitis—Pamidronate—osteoporosis	0.000384	0.000694	CcSEcCtD
Ipratropium bromide—Dyspnoea—Estradiol—osteoporosis	0.000383	0.000692	CcSEcCtD
Ipratropium bromide—Headache—Pamidronate—osteoporosis	0.000382	0.00069	CcSEcCtD
Ipratropium bromide—Somnolence—Estradiol—osteoporosis	0.000382	0.00069	CcSEcCtD
Ipratropium bromide—Diarrhoea—Zoledronate—osteoporosis	0.000381	0.000689	CcSEcCtD
Ipratropium bromide—Nausea—Risedronate—osteoporosis	0.000381	0.000689	CcSEcCtD
Ipratropium bromide—Pruritus—Conjugated Estrogens—osteoporosis	0.000379	0.000686	CcSEcCtD
Ipratropium bromide—Dyspepsia—Estradiol—osteoporosis	0.000378	0.000683	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Estradiol—osteoporosis	0.00037	0.00067	CcSEcCtD
Ipratropium bromide—Fatigue—Estradiol—osteoporosis	0.00037	0.000669	CcSEcCtD
Ipratropium bromide—Dizziness—Zoledronate—osteoporosis	0.000368	0.000666	CcSEcCtD
Ipratropium bromide—Pain—Estradiol—osteoporosis	0.000367	0.000663	CcSEcCtD
Ipratropium bromide—Constipation—Estradiol—osteoporosis	0.000367	0.000663	CcSEcCtD
Ipratropium bromide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000367	0.000663	CcSEcCtD
Ipratropium bromide—Nausea—Pamidronate—osteoporosis	0.000362	0.000655	CcSEcCtD
Ipratropium bromide—Dizziness—Conjugated Estrogens—osteoporosis	0.000355	0.000641	CcSEcCtD
Ipratropium bromide—Vomiting—Zoledronate—osteoporosis	0.000354	0.00064	CcSEcCtD
Ipratropium bromide—Rash—Zoledronate—osteoporosis	0.000351	0.000635	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Estradiol—osteoporosis	0.000351	0.000634	CcSEcCtD
Ipratropium bromide—Dermatitis—Zoledronate—osteoporosis	0.000351	0.000634	CcSEcCtD
Ipratropium bromide—Headache—Zoledronate—osteoporosis	0.000349	0.000631	CcSEcCtD
Ipratropium bromide—Vomiting—Conjugated Estrogens—osteoporosis	0.000341	0.000616	CcSEcCtD
Ipratropium bromide—Urticaria—Estradiol—osteoporosis	0.000341	0.000616	CcSEcCtD
Ipratropium bromide—Abdominal pain—Estradiol—osteoporosis	0.000339	0.000613	CcSEcCtD
Ipratropium bromide—Rash—Conjugated Estrogens—osteoporosis	0.000338	0.000611	CcSEcCtD
Ipratropium bromide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000338	0.000611	CcSEcCtD
Ipratropium bromide—Headache—Conjugated Estrogens—osteoporosis	0.000336	0.000607	CcSEcCtD
Ipratropium bromide—Nausea—Zoledronate—osteoporosis	0.000331	0.000598	CcSEcCtD
Ipratropium bromide—Nausea—Conjugated Estrogens—osteoporosis	0.000318	0.000576	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Estradiol—osteoporosis	0.000316	0.000571	CcSEcCtD
Ipratropium bromide—Asthenia—Estradiol—osteoporosis	0.000308	0.000557	CcSEcCtD
Ipratropium bromide—Pruritus—Estradiol—osteoporosis	0.000304	0.000549	CcSEcCtD
Ipratropium bromide—Diarrhoea—Estradiol—osteoporosis	0.000294	0.000531	CcSEcCtD
Ipratropium bromide—Dizziness—Estradiol—osteoporosis	0.000284	0.000513	CcSEcCtD
Ipratropium bromide—Vomiting—Estradiol—osteoporosis	0.000273	0.000493	CcSEcCtD
Ipratropium bromide—Rash—Estradiol—osteoporosis	0.000271	0.000489	CcSEcCtD
Ipratropium bromide—Dermatitis—Estradiol—osteoporosis	0.00027	0.000489	CcSEcCtD
Ipratropium bromide—Headache—Estradiol—osteoporosis	0.000269	0.000486	CcSEcCtD
Ipratropium bromide—Nausea—Estradiol—osteoporosis	0.000255	0.000461	CcSEcCtD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CNR2—osteoporosis	1.68e-06	0.00166	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MGLL—osteoporosis	1.67e-06	0.00166	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	1.66e-06	0.00165	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—POMC—osteoporosis	1.66e-06	0.00164	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CALCA—osteoporosis	1.63e-06	0.00161	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.6e-06	0.00159	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.58e-06	0.00157	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TLN1—osteoporosis	1.57e-06	0.00156	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PTH—osteoporosis	1.57e-06	0.00156	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PTH—osteoporosis	1.56e-06	0.00155	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PTH—osteoporosis	1.55e-06	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.53e-06	0.00152	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CNR2—osteoporosis	1.53e-06	0.00152	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.53e-06	0.00152	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CNR2—osteoporosis	1.52e-06	0.00151	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.51e-06	0.0015	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CNR2—osteoporosis	1.51e-06	0.0015	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—POMC—osteoporosis	1.47e-06	0.00146	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—WNT1—osteoporosis	1.44e-06	0.00143	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—WNT1—osteoporosis	1.43e-06	0.00142	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	1.43e-06	0.00142	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	1.43e-06	0.00142	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	1.42e-06	0.00141	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—IDH2—osteoporosis	1.42e-06	0.00141	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—WNT1—osteoporosis	1.42e-06	0.00141	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	1.41e-06	0.0014	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MGLL—osteoporosis	1.4e-06	0.00139	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MGLL—osteoporosis	1.4e-06	0.00139	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PKM—osteoporosis	1.39e-06	0.00138	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—FDPS—osteoporosis	1.39e-06	0.00138	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MGLL—osteoporosis	1.38e-06	0.00137	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LRP5—osteoporosis	1.37e-06	0.00136	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LRP5—osteoporosis	1.36e-06	0.00135	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—P4HB—osteoporosis	1.35e-06	0.00134	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LRP5—osteoporosis	1.35e-06	0.00134	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP27A1—osteoporosis	1.34e-06	0.00132	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PGLS—osteoporosis	1.32e-06	0.00131	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPD2—osteoporosis	1.32e-06	0.00131	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PTH—osteoporosis	1.32e-06	0.00131	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LRP6—osteoporosis	1.31e-06	0.0013	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LRP6—osteoporosis	1.3e-06	0.00129	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	1.3e-06	0.00129	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ACP5—osteoporosis	1.3e-06	0.00129	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	1.3e-06	0.00129	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RAP1A—osteoporosis	1.29e-06	0.00128	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LRP6—osteoporosis	1.29e-06	0.00128	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	1.28e-06	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CNR2—osteoporosis	1.28e-06	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.28e-06	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	1.27e-06	0.00126	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NFATC1—osteoporosis	1.26e-06	0.00125	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	1.26e-06	0.00125	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	1.26e-06	0.00125	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DKK1—osteoporosis	1.25e-06	0.00124	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	1.24e-06	0.00123	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—TPI1—osteoporosis	1.21e-06	0.0012	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—WNT1—osteoporosis	1.21e-06	0.0012	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PNP—osteoporosis	1.21e-06	0.0012	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ATIC—osteoporosis	1.21e-06	0.0012	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGA—osteoporosis	1.17e-06	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—POMC—osteoporosis	1.17e-06	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—POMC—osteoporosis	1.16e-06	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	1.16e-06	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—POMC—osteoporosis	1.15e-06	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	1.15e-06	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CALCA—osteoporosis	1.14e-06	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CALCA—osteoporosis	1.14e-06	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—P4HB—osteoporosis	1.14e-06	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CALCA—osteoporosis	1.13e-06	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GAPDH—osteoporosis	1.12e-06	0.00111	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TLN1—osteoporosis	1.11e-06	0.0011	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TLN1—osteoporosis	1.1e-06	0.00109	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—BMP2—osteoporosis	1.09e-06	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PTHLH—osteoporosis	1.09e-06	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TLN1—osteoporosis	1.09e-06	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—RAP1A—osteoporosis	1.09e-06	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGB—osteoporosis	1.07e-06	0.00106	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PSMA2—osteoporosis	1.03e-06	0.00102	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PSMA5—osteoporosis	1.03e-06	0.00102	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CA2—osteoporosis	1.03e-06	0.00102	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—OXCT1—osteoporosis	1.03e-06	0.00102	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MGLL—osteoporosis	9.99e-07	0.000991	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—POMC—osteoporosis	9.64e-07	0.000956	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CALCA—osteoporosis	9.6e-07	0.000952	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—P4HB—osteoporosis	9.53e-07	0.000945	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—P4HB—osteoporosis	9.5e-07	0.000942	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—IL6—osteoporosis	9.49e-07	0.000941	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—P4HB—osteoporosis	9.41e-07	0.000933	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—POMC—osteoporosis	9.37e-07	0.000929	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTH—osteoporosis	9.27e-07	0.000919	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTH—osteoporosis	9.24e-07	0.000916	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTH—osteoporosis	9.15e-07	0.000907	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RAP1A—osteoporosis	9.11e-07	0.000903	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PKM—osteoporosis	9.09e-07	0.000902	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—FDPS—osteoporosis	9.09e-07	0.000902	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RAP1A—osteoporosis	9.08e-07	0.000901	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CNR2—osteoporosis	9.03e-07	0.000896	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CNR2—osteoporosis	9.01e-07	0.000893	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	8.99e-07	0.000892	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RAP1A—osteoporosis	8.99e-07	0.000892	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	8.97e-07	0.000889	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	8.97e-07	0.000889	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	8.94e-07	0.000886	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CNR2—osteoporosis	8.92e-07	0.000884	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NFATC1—osteoporosis	8.89e-07	0.000881	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NFATC1—osteoporosis	8.86e-07	0.000879	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	8.85e-07	0.000878	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DKK1—osteoporosis	8.82e-07	0.000874	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DKK1—osteoporosis	8.79e-07	0.000872	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ENO1—osteoporosis	8.78e-07	0.000871	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NFATC1—osteoporosis	8.77e-07	0.00087	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KL—osteoporosis	8.72e-07	0.000865	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DKK1—osteoporosis	8.7e-07	0.000863	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PSMA2—osteoporosis	8.65e-07	0.000858	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PSMA5—osteoporosis	8.65e-07	0.000858	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPD2—osteoporosis	8.62e-07	0.000855	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PGLS—osteoporosis	8.62e-07	0.000855	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—POMC—osteoporosis	8.51e-07	0.000844	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—IDH2—osteoporosis	8.5e-07	0.000843	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—WNT1—osteoporosis	8.49e-07	0.000842	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—WNT1—osteoporosis	8.47e-07	0.00084	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—WNT1—osteoporosis	8.38e-07	0.000831	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6R—osteoporosis	8.3e-07	0.000823	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGA—osteoporosis	8.26e-07	0.000819	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGA—osteoporosis	8.24e-07	0.000817	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGA—osteoporosis	8.16e-07	0.000809	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	8.14e-07	0.000807	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	8.12e-07	0.000805	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	8.04e-07	0.000797	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP27A1—osteoporosis	7.99e-07	0.000792	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ATIC—osteoporosis	7.88e-07	0.000782	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PNP—osteoporosis	7.88e-07	0.000782	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ACP5—osteoporosis	7.77e-07	0.000771	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—BMP2—osteoporosis	7.68e-07	0.000762	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTHLH—osteoporosis	7.68e-07	0.000762	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTHLH—osteoporosis	7.66e-07	0.000759	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—BMP2—osteoporosis	7.66e-07	0.000759	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTHLH—osteoporosis	7.58e-07	0.000752	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—BMP2—osteoporosis	7.58e-07	0.000752	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGB—osteoporosis	7.52e-07	0.000745	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGB—osteoporosis	7.49e-07	0.000743	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGB—osteoporosis	7.42e-07	0.000736	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PSMA2—osteoporosis	7.26e-07	0.00072	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PSMA5—osteoporosis	7.26e-07	0.00072	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PSMA2—osteoporosis	7.23e-07	0.000717	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PSMA5—osteoporosis	7.23e-07	0.000717	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TPI1—osteoporosis	7.22e-07	0.000716	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PSMA2—osteoporosis	7.16e-07	0.00071	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PSMA5—osteoporosis	7.16e-07	0.00071	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP19A1—osteoporosis	7.02e-07	0.000696	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADCY5—osteoporosis	6.83e-07	0.000677	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—P4HB—osteoporosis	6.79e-07	0.000674	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CALCA—osteoporosis	6.76e-07	0.000671	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CALCA—osteoporosis	6.74e-07	0.000668	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CA2—osteoporosis	6.7e-07	0.000665	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—OXCT1—osteoporosis	6.7e-07	0.000665	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CALCA—osteoporosis	6.68e-07	0.000662	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GAPDH—osteoporosis	6.67e-07	0.000661	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SPP1—osteoporosis	6.61e-07	0.000655	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—POMC—osteoporosis	6.6e-07	0.000654	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—POMC—osteoporosis	6.57e-07	0.000652	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MGLL—osteoporosis	6.53e-07	0.000648	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—POMC—osteoporosis	6.51e-07	0.000646	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—RAP1A—osteoporosis	6.49e-07	0.000644	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KL—osteoporosis	6.14e-07	0.000609	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KL—osteoporosis	6.12e-07	0.000607	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KL—osteoporosis	6.06e-07	0.000601	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—POMC—osteoporosis	5.99e-07	0.000594	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IRS2—osteoporosis	5.98e-07	0.000593	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—POMC—osteoporosis	5.97e-07	0.000592	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—POMC—osteoporosis	5.91e-07	0.000586	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—LEP—osteoporosis	5.85e-07	0.00058	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6R—osteoporosis	5.84e-07	0.000579	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6R—osteoporosis	5.82e-07	0.000578	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6R—osteoporosis	5.77e-07	0.000572	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ADCY5—osteoporosis	5.73e-07	0.000569	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GPX1—osteoporosis	5.71e-07	0.000567	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ESR1—osteoporosis	5.58e-07	0.000554	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—IDH2—osteoporosis	5.56e-07	0.000551	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MTHFR—osteoporosis	5.27e-07	0.000523	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ENO1—osteoporosis	5.25e-07	0.000521	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.22e-07	0.000518	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IRS1—osteoporosis	5.22e-07	0.000517	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSMA5—osteoporosis	5.17e-07	0.000513	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSMA2—osteoporosis	5.17e-07	0.000513	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ACP5—osteoporosis	5.08e-07	0.000504	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—POMC—osteoporosis	5.03e-07	0.000498	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6R—osteoporosis	4.9e-07	0.000486	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF1—osteoporosis	4.83e-07	0.000479	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADCY5—osteoporosis	4.81e-07	0.000477	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADCY5—osteoporosis	4.8e-07	0.000475	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADCY5—osteoporosis	4.75e-07	0.000471	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TPI1—osteoporosis	4.72e-07	0.000468	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SPP1—osteoporosis	4.65e-07	0.000461	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SPP1—osteoporosis	4.64e-07	0.00046	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SPP1—osteoporosis	4.59e-07	0.000456	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—P4HB—osteoporosis	4.44e-07	0.00044	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GAPDH—osteoporosis	4.36e-07	0.000432	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—RAP1A—osteoporosis	4.25e-07	0.000421	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—POMC—osteoporosis	4.22e-07	0.000418	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS2—osteoporosis	4.21e-07	0.000417	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.2e-07	0.000416	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS2—osteoporosis	4.2e-07	0.000416	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS2—osteoporosis	4.15e-07	0.000412	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LEP—osteoporosis	4.12e-07	0.000408	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LEP—osteoporosis	4.11e-07	0.000407	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LEP—osteoporosis	4.07e-07	0.000403	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ESR1—osteoporosis	3.93e-07	0.00039	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ESR1—osteoporosis	3.92e-07	0.000389	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ESR1—osteoporosis	3.88e-07	0.000385	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—osteoporosis	3.7e-07	0.000367	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS1—osteoporosis	3.67e-07	0.000364	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS1—osteoporosis	3.66e-07	0.000363	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS1—osteoporosis	3.63e-07	0.00036	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—POMC—osteoporosis	3.54e-07	0.000351	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—POMC—osteoporosis	3.53e-07	0.00035	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—POMC—osteoporosis	3.49e-07	0.000346	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6R—osteoporosis	3.45e-07	0.000342	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6R—osteoporosis	3.44e-07	0.000341	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ENO1—osteoporosis	3.43e-07	0.00034	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADCY5—osteoporosis	3.43e-07	0.00034	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—osteoporosis	3.42e-07	0.000339	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6R—osteoporosis	3.41e-07	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1—osteoporosis	3.4e-07	0.000337	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1—osteoporosis	3.39e-07	0.000336	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMA2—osteoporosis	3.38e-07	0.000335	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMA5—osteoporosis	3.38e-07	0.000335	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1—osteoporosis	3.36e-07	0.000333	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—osteoporosis	3.15e-07	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—osteoporosis	2.9e-07	0.000288	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—osteoporosis	2.9e-07	0.000287	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.74e-07	0.000272	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—osteoporosis	2.6e-07	0.000258	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—osteoporosis	2.59e-07	0.000257	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—osteoporosis	2.57e-07	0.000255	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—POMC—osteoporosis	2.52e-07	0.00025	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADCY5—osteoporosis	2.24e-07	0.000222	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—osteoporosis	2.23e-07	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—osteoporosis	2.18e-07	0.000217	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—osteoporosis	2.06e-07	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—osteoporosis	2.05e-07	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—osteoporosis	2.04e-07	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—osteoporosis	2.04e-07	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—osteoporosis	2.03e-07	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—osteoporosis	2.02e-07	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—osteoporosis	2.01e-07	0.0002	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—POMC—osteoporosis	1.65e-07	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—osteoporosis	1.54e-07	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—osteoporosis	1.53e-07	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—osteoporosis	1.52e-07	0.000151	CbGpPWpGaD
